Indrayani Biotech Rights Issue 2026 Details, Record Date, Issue Price

Indrayani Biotech Rights Issue details are now available. The firm plans to issue 3,25,25,897 equity shares amounting to ₹48.79 crores. Indrayani Biotech Rights issue price is ₹15 per share, and the face value is ₹10 per share.

Indrayani Biotech Rights Issue open date is May 27, 2026 and the closing date is June 25, 2026. Indrayani Biotech rights issue entitlement ratio is 5:7, which is 5 Rights Equity Share(s) for every 7 fully paid-up Equity Share(s) held on the record date.

Indrayani Biotech Rights Issue record date is April 28, 2026. The last date to buy shares of Indrayani Biotech is April 27, 2026. This rights Issue subscription status will be available soon.

Indrayani Biotech Rights Issue allotment date, credit date and the listing date will be available soon. However, the listing will be on the BSE. Indrayani Biotech rights issue registrar is MUFG Intime India Private Limited.

Also Read | Automobile Products of India Rights Issue 2026 Details, Record Date, Issue Price

Indrayani Biotech Rights Issue Details

Indrayani Biotech Rights Issue details are as follows: the company plans to issue 3,25,25,897 equity shares, aggregating the amount of ₹48.79 crores. Indrayani Biotech Rights issue price is ₹15 per share. The rights issue entitlement ratio is 5:7, which is 5 Rights Equity Share(s) for every 7 fully paid-up Equity Share(s).

Indrayani Biotech Rights Issue Dates

Indrayani Biotech Rights issue record date is April 28, 2026 and the last date to buy shares of Indrayani Biotech is April 27, 2026.

Indrayani Biotech Rights Issue Subscription

Indrayani Biotech Rights Issue subscription status will be available after the issue goes live. The details of the Rights Issue entitlement are 5 Rights Equity Share(s) for every 7 fully paid-up Equity Share(s) held on the Record Date. Indrayani Biotech issue price is ₹15 per share.

Indrayani Biotech Limited: About the Company

Manipal Health Enterprises Limited is the company behind Manipal Hospitals, one of India’s well-known healthcare networks with a focus on multi-specialty treatment, patient care, and medical excellence. Incorporated in 2010, the group traces its hospital roots to 1991, when its flagship Manipal Hospital began operations in Bengaluru; its broader legacy is linked to the Manipal Group and the medical vision of Dr. T. M. A. Pai.

Today, the company operates a large hospital network across India, with multiple hospitals, thousands of beds, and services that span diagnostics, critical care, surgery, and specialized treatment. Its work is centered on ethical care, accessible healthcare delivery, and modern clinical infrastructure, supported by experienced doctors and healthcare professionals. For SEO-friendly company content, Manipal Health Enterprises Limited can be described as a healthcare company in India that delivers trusted multi-specialty hospital services through a strong national network.

Indrayani Biotech Limited Financials (Amount in ₹crore)

FAQs

1. What are the details of the Indrayani Biotech Rights Issue?

Indrayani Biotech Rights Issue details are as follows: Indrayani Biotech plans to issue 3,25,25,897 equity shares amounting to ₹48.79 crores. Indrayani Biotech Rights issue price is ₹15 per share, and the face value is ₹10 per share. The rights issue entitlement ratio is 5:7, which is 5 Rights Equity Share(s) for every 7 fully paid-up Equity Share(s).

2. Indrayani Biotech Rights Issue open date and close date?

Indrayani Biotech Rights Issue's open date is May 27, 2026, and the closing date is June 25, 2026. Indrayani Biotech Rights Issue record date is April 28, 2026. The last date to buy shares of Indrayani Biotech is April 27, 2026.

3. How can I apply for the Indrayani Biotech Rights Issue?

You can apply for Indrayani Biotech in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Indrayani Biotech Rights Issue?

Indrayani Biotech rights issue entitlement ratio is 5:7, which is 5 Rights Equity Share(s) for every 7 fully paid-up Equity Share(s).

5. How can I check the Indrayani Biotech Issue Allotment Status?

The registrar for the Indrayani Biotech rights Issue is MUFG Intime India Private Limited, Investors can check the allotment status by visiting the registrar's website.

6. From where can I get the Indrayani Biotech Rights Issue Letter of Offer?

You can download the Indrayani Biotech Rights Issue Letter of Offer from here.

7. What is the listing date of the Indrayani Biotech Rights Issue?

The Indrayani Biotech Rights Issue listing date is not yet disclosed. However, the listing will be on the BSE.

8. Who is the registrar and the lead manager of the Indrayani Biotech Rights Issue?

Indrayani Biotech rights issue registrar is MUFG Intime India Private Limited.

Also Read | Gravity India Rights Issue 2026 Details, Record Date, Issue Price